Overproduction of K1 Enzyme in Klebsiella oxytoca Clinical Isolates Against Ceftazidime, Cefepime and Ceftobiprole

被引：0

作者：

Corvec, S. ^{[1
]}

Cremet, L. ^{[1
]}

Lepelletier, D. ^{[1
]}

Reynaud, A. ^{[1
]}

Drugeon, H. ^{[1
]}

机构：

[1] CHU Nantes, Serv Bacteriol Hyg Hosp, F-44049 Nantes 01, France

来源：

JOURNAL OF CHEMOTHERAPY | 2009年 / 21卷 / 03期

关键词：

D O I：

10.1179/joc.2009.21.3.365

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：365 / 366

页数：2

共 50 条

[21] In vitro activity of ceftazidime, cefepime and imipenem on 1,005 Pseudomonas aeruginosa clinical isolates either susceptible or resistant to beta-lactams
Bonfiglio, G
Marchetti, F
CHEMOTHERAPY, 2000, 46 (04) : 229 - 234
[22] Investigation of the putative virulence gene magA in a worldwide collection of 495 Klebsiella isolates:: magA is restricted to the gene cluster of Klebsiella pneumoniae capsule serotype K1
Struve, C
Bojer, M
Nielsen, EM
Hansen, DS
Krogfelt, KA
JOURNAL OF MEDICAL MICROBIOLOGY, 2005, 54 (11) : 1111 - 1113
[23] Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteins
Brisse, S
Milatovic, D
Fluit, AC
Verhoef, J
Martin, N
Scheuring, S
Köhrer, K
Schmitz, FJ
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) : 2051 - 2055
[24] Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypes
Yu, Wen-Liang
Ko, Wen-Chien
Cheng, Kuo-Chen
Lee, Ching-Chien
Lai, Chien-Cherng
Chuang, Yin-Ching
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2008, 62 (01) : 1 - 6
[25] The Potential Use of Ceftazidime-Avibactam Against Carbapenem Resistant Klebsiella pneumoniae Clinical Isolates Harboring Different Carbapenemase Types in a Thai University Hospital
Nasomsong, Worapong
Nulsopapon, Parnrada
Changpradub, Dhitiwat
Pongchaidecha, Manat
Pungcharoenkijkul, Supanun
Juntanawiwat, Piraporn
Simsiriporn, Waristha
Santimaleeworagun, Wichai
DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 3095 - 3104
[26] High Prevalence of Plasmid-Mediated Quinolone Resistance Determinants Among Serotype K1 Hypervirulent Klebsiella pneumoniae Isolates in China
Liu, Yang
Du, Fang-ling
Xiang, Tian-xin
Wan, La-Gen
Wei, Dan-dan
Cao, Xian-Wei
Zhang, Wei
MICROBIAL DRUG RESISTANCE, 2019, 25 (05) : 681 - 689
[27] Dissemination of Clinical Isolates of Klebsiella oxytoca Harboring CMY-31, VIM-1, and a New OXY-2-Type Variant in the Community
Tsakris, Athanassios
Poulou, Aggeliki
Markou, Fani
Pitiriga, Vassiliki
Piperaki, Evangelia-Theophano
Kristo, Ioulia
Pournaras, Spyros
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (07) : 3164 - 3168
[28] Structural and biological insights into Klebsiella pneumoniae surface polysaccharide degradation by a bacteriophage K1 lyase: implications for clinical use
Tu, I-Fan
Lin, Tzu-Lung
Yang, Feng-Ling
Lee, I-Ming
Tu, Wei-Lin
Liao, Jiahn-Haur
Ko, Tzu-Ping
Wu, Wen-Jin
Jan, Jia-Tsrong
Ho, Meng-Ru
Chou, Ching-Yi
Wang, Andrew H-J
Wu, Chung-Yi
Wang, Jin-Town
Huang, Kai-Fa
Wu, Shih-Hsiung
JOURNAL OF BIOMEDICAL SCIENCE, 2022, 29 (01)
[29] Structural and biological insights into Klebsiella pneumoniae surface polysaccharide degradation by a bacteriophage K1 lyase: implications for clinical use
I-Fan Tu
Tzu-Lung Lin
Feng-Ling Yang
I-Ming Lee
Wei-Lin Tu
Jiahn-Haur Liao
Tzu-Ping Ko
Wen-Jin Wu
Jia-Tsrong Jan
Meng-Ru Ho
Ching-Yi Chou
Andrew H.-J. Wang
Chung-Yi Wu
Jin-Town Wang
Kai-Fa Huang
Shih-Hsiung Wu
Journal of Biomedical Science, 29
[30] Role of CD14 in responses to clinical isolates of Escherichia coli:: Effects of K1 capsule expression
Metkar, Shalaka
Awasthi, Shanjana
Denamur, Erick
Kim, Kwang Sik
Gangloff, Sophie C.
Teichberg, Saul
Haziot, Alain
Silver, Jack
Goyert, Sanna M.
INFECTION AND IMMUNITY, 2007, 75 (11) : 5415 - 5424

← 1 2 3 4 5 →